Genomic profile of MYCN non-amplified neuroblastoma and potential for immunotherapeutic strategies in neuroblastoma

• Egile Nagusiak: Eunjin Lee (Egilea), Ji Won Lee (Egilea), Boram Lee (Egilea), Kyunghee Park (Egilea), Joonho Shim (Egilea), Keon Hee Yoo (Egilea), Hong Hoe Koo (Egilea), Ki Woong Sung (Egilea), Woong-Yang Park (Egilea)
• Formatua: Liburua
• Argitaratua: BMC, 2020-11-01T00:00:00Z.
• Gaiak: article
• Sarrera elektronikoa: Connect to this object online.

Abstract Background MYCN amplification is the most important genomic feature in neuroblastoma (NB). However, limited studies have been conducted on the MYCN non-amplified NB including low- and intermediate-risk NB. Here, the genomic characteristics of MYCN non-amplified NB were studied to allow for...